Skip to main content
. 2022 Sep 1;31(3):153–161. doi: 10.1080/10669817.2022.2113295

Table 3.

Summary of settings, clinicians, and neck pain phenotypes represented in MT trials.

Characteristic 113 Total Trials
N (% of all MT Trials)
Country of origin  
United States 20 (17.7)
Spain 19 (16.8)
India 13 (11.5)
Not specified 9 (8.0)
Pakistan 7 (6.2)
Turkey 5 (4.4)
Australia 4 (3.5)
Egypt 4 (3.5)
Korea 4 (3.5)
Canada 3 (2.7)
Netherlands 3 (2.7)
Sweden 3 (2.7)
Thailand 3 (2.7)
Hong Kong 2 (1.8)
Brazil 2 (1.8)
Germany 2 (1.8)
Iran 2 (1.8)
Nigeria 2 (1.8)
Norway 1 (0.9)
Poland 1 (0.9)
Portugal 1 (0.9)
Saudi Arabia 1 (0.9)
South Africa 1 (0.9)
New Zealand 1 (0.9)
Neck pain type  
Nonspecific 77 (68.1)
Cervicogenic headache 15 (13.3)
Radiculopathy 14 (12.4)
All types 6 (5.3)
Whiplash 1 (0.9)
Study/clinical setting  
Not specified 32 (28.3)
University 30 (26.5)
Private 25 (22.1)
Hospital 21 (18.6)
Research laboratory 5 (4.4)
Clinician  
Physical Therapist 88 (77.9)
Chiropractor 12 (10.6)
Not specified 6 (5.3)
Osteopath 3 (2.7)
Naprapath 2 (1.8)
Medical Doctor 1 (0.9)
Physical Therapist, Osteopath, and Chiropractor 1 (0.9)